Pfizer

Lipitor(atorvastain calcium) tablets made by Pfizer and distributed by Parke-Davis are seen November 30, 2011 in Washington, DC. Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on November 30, 2011, opening the path to generic competitors for America's most popular medication. Lipitor came on the market in 1997, and has raked in some $100 billion for Pfizer even in a crowded market that includes various other cholesterol-lowering statins, many of which have already gone generic. In the United States, anti-cholesterol drugs account for 255 million prescriptions a year, and about nine million people are taking Lipitor. AFP Photo/Paul J. Richards (Photo: PAUL J. RICHARDS/AFP/Getty Images)

Risk Of Glass Particles In Generic Lipitor Prompts FDA Recall

Ranbaxy Pharmaceuticals Inc. is recalling more than 40 lots of atorvastatin pills — the generic version of the popular statin Lipitor — over possible glass contamination.

CBS4–11/23/2012

(Source: FDA) Pfizer Announces Voluntary Nationwide Recall of Lo/Ovral®-28 and Norgestrel/Ethinyl Estradiol Tablets due to possibility of Inexact Tablet Counts or Out of Sequence Tablets

Pfizer Recalls 1M Birth Control Packs After Mixup

Take a close look at your birth control pills ladies because Pfizer is recalling a million birth control packets because of a packaging error. Some of the packs have an inadequate dose of hormones which could raise the risk of pregnancy.

CBS4–02/01/2012

pills

Generic Versions Of Lipitor On The Way

Cheaper generic versions of the popular cholesterol lowering drug Lipitor will soon be hitting the market. Pfizer Inc.’s patent protection for Lipitor expires on Wednesday.

CBS4–11/30/2011

Follow

Get every new post delivered to your Inbox.

Join 1,539 other followers